Global Artemisinin Combination Therapy Market Research Report 2024(Status and Outlook)

Global Artemisinin Combination Therapy Market Research Report 2024(Status and Outlook)



Report Overview:

Artemisinin Combination Therapy is recommended for thetreatmentof P. falciparum malaria. Fast actingartemisinin-based compounds arecombinedwith a drug from a different class and artemisinin derivatives include dihydroartemisinin, artesunate and artemether.

The Global Artemisinin Combination Therapy Market Size was estimated at USD 377.13 million in 2023 and is projected to reach USD 499.65 million by 2029, exhibiting a CAGR of 4.80% during the forecast period.

This report provides a deep insight into the global Artemisinin Combination Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Artemisinin Combination Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Artemisinin Combination Therapy market in any manner.

Global Artemisinin Combination Therapy Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

KPC Pharmaceuticals

Shanghai Fosun Pharmaceutical Industrial Development

Sanofi

Desano Holdings

Calyx Chemicals and Pharmaceuticals

Mylan

Novartis

Denk Pharma

Hovid Berhad

Ipca Laboratories

Cipla

Aspen Pharmacare Holdings

Ajanta Pharma

Guilin Pharmaceuticals

Market Segmentation (by Type)

Artemether+Lumefantrine

Artesunate+Amodiaquine

Dihydroartemisinin+Piperaquine

Artesunate+Mefloquine

Artesunate+Sulfadoxine-Pyrimethamine

Pyronaridine-Artesunate

Other

Market Segmentation (by Application)

Hospital

Clinic

Other

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Artemisinin Combination Therapy Market

Overview of the regional outlook of the Artemisinin Combination Therapy Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Artemisinin Combination Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Artemisinin Combination Therapy
1.2 Key Market Segments
1.2.1 Artemisinin Combination Therapy Segment by Type
1.2.2 Artemisinin Combination Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Artemisinin Combination Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Artemisinin Combination Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Artemisinin Combination Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Artemisinin Combination Therapy Market Competitive Landscape
3.1 Global Artemisinin Combination Therapy Sales by Manufacturers (2019-2024)
3.2 Global Artemisinin Combination Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Artemisinin Combination Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Artemisinin Combination Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Artemisinin Combination Therapy Sales Sites, Area Served, Product Type
3.6 Artemisinin Combination Therapy Market Competitive Situation and Trends
3.6.1 Artemisinin Combination Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Artemisinin Combination Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Artemisinin Combination Therapy Industry Chain Analysis
4.1 Artemisinin Combination Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Artemisinin Combination Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Artemisinin Combination Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Artemisinin Combination Therapy Sales Market Share by Type (2019-2024)
6.3 Global Artemisinin Combination Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Artemisinin Combination Therapy Price by Type (2019-2024)
7 Artemisinin Combination Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Artemisinin Combination Therapy Market Sales by Application (2019-2024)
7.3 Global Artemisinin Combination Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Artemisinin Combination Therapy Sales Growth Rate by Application (2019-2024)
8 Artemisinin Combination Therapy Market Segmentation by Region
8.1 Global Artemisinin Combination Therapy Sales by Region
8.1.1 Global Artemisinin Combination Therapy Sales by Region
8.1.2 Global Artemisinin Combination Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Artemisinin Combination Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Artemisinin Combination Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Artemisinin Combination Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Artemisinin Combination Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Artemisinin Combination Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 KPC Pharmaceuticals
9.1.1 KPC Pharmaceuticals Artemisinin Combination Therapy Basic Information
9.1.2 KPC Pharmaceuticals Artemisinin Combination Therapy Product Overview
9.1.3 KPC Pharmaceuticals Artemisinin Combination Therapy Product Market Performance
9.1.4 KPC Pharmaceuticals Business Overview
9.1.5 KPC Pharmaceuticals Artemisinin Combination Therapy SWOT Analysis
9.1.6 KPC Pharmaceuticals Recent Developments
9.2 Shanghai Fosun Pharmaceutical Industrial Development
9.2.1 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Basic Information
9.2.2 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product Overview
9.2.3 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product Market Performance
9.2.4 Shanghai Fosun Pharmaceutical Industrial Development Business Overview
9.2.5 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy SWOT Analysis
9.2.6 Shanghai Fosun Pharmaceutical Industrial Development Recent Developments
9.3 Sanofi
9.3.1 Sanofi Artemisinin Combination Therapy Basic Information
9.3.2 Sanofi Artemisinin Combination Therapy Product Overview
9.3.3 Sanofi Artemisinin Combination Therapy Product Market Performance
9.3.4 Sanofi Artemisinin Combination Therapy SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Desano Holdings
9.4.1 Desano Holdings Artemisinin Combination Therapy Basic Information
9.4.2 Desano Holdings Artemisinin Combination Therapy Product Overview
9.4.3 Desano Holdings Artemisinin Combination Therapy Product Market Performance
9.4.4 Desano Holdings Business Overview
9.4.5 Desano Holdings Recent Developments
9.5 Calyx Chemicals and Pharmaceuticals
9.5.1 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Basic Information
9.5.2 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product Overview
9.5.3 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product Market Performance
9.5.4 Calyx Chemicals and Pharmaceuticals Business Overview
9.5.5 Calyx Chemicals and Pharmaceuticals Recent Developments
9.6 Mylan
9.6.1 Mylan Artemisinin Combination Therapy Basic Information
9.6.2 Mylan Artemisinin Combination Therapy Product Overview
9.6.3 Mylan Artemisinin Combination Therapy Product Market Performance
9.6.4 Mylan Business Overview
9.6.5 Mylan Recent Developments
9.7 Novartis
9.7.1 Novartis Artemisinin Combination Therapy Basic Information
9.7.2 Novartis Artemisinin Combination Therapy Product Overview
9.7.3 Novartis Artemisinin Combination Therapy Product Market Performance
9.7.4 Novartis Business Overview
9.7.5 Novartis Recent Developments
9.8 Denk Pharma
9.8.1 Denk Pharma Artemisinin Combination Therapy Basic Information
9.8.2 Denk Pharma Artemisinin Combination Therapy Product Overview
9.8.3 Denk Pharma Artemisinin Combination Therapy Product Market Performance
9.8.4 Denk Pharma Business Overview
9.8.5 Denk Pharma Recent Developments
9.9 Hovid Berhad
9.9.1 Hovid Berhad Artemisinin Combination Therapy Basic Information
9.9.2 Hovid Berhad Artemisinin Combination Therapy Product Overview
9.9.3 Hovid Berhad Artemisinin Combination Therapy Product Market Performance
9.9.4 Hovid Berhad Business Overview
9.9.5 Hovid Berhad Recent Developments
9.10 Ipca Laboratories
9.10.1 Ipca Laboratories Artemisinin Combination Therapy Basic Information
9.10.2 Ipca Laboratories Artemisinin Combination Therapy Product Overview
9.10.3 Ipca Laboratories Artemisinin Combination Therapy Product Market Performance
9.10.4 Ipca Laboratories Business Overview
9.10.5 Ipca Laboratories Recent Developments
9.11 Cipla
9.11.1 Cipla Artemisinin Combination Therapy Basic Information
9.11.2 Cipla Artemisinin Combination Therapy Product Overview
9.11.3 Cipla Artemisinin Combination Therapy Product Market Performance
9.11.4 Cipla Business Overview
9.11.5 Cipla Recent Developments
9.12 Aspen Pharmacare Holdings
9.12.1 Aspen Pharmacare Holdings Artemisinin Combination Therapy Basic Information
9.12.2 Aspen Pharmacare Holdings Artemisinin Combination Therapy Product Overview
9.12.3 Aspen Pharmacare Holdings Artemisinin Combination Therapy Product Market Performance
9.12.4 Aspen Pharmacare Holdings Business Overview
9.12.5 Aspen Pharmacare Holdings Recent Developments
9.13 Ajanta Pharma
9.13.1 Ajanta Pharma Artemisinin Combination Therapy Basic Information
9.13.2 Ajanta Pharma Artemisinin Combination Therapy Product Overview
9.13.3 Ajanta Pharma Artemisinin Combination Therapy Product Market Performance
9.13.4 Ajanta Pharma Business Overview
9.13.5 Ajanta Pharma Recent Developments
9.14 Guilin Pharmaceuticals
9.14.1 Guilin Pharmaceuticals Artemisinin Combination Therapy Basic Information
9.14.2 Guilin Pharmaceuticals Artemisinin Combination Therapy Product Overview
9.14.3 Guilin Pharmaceuticals Artemisinin Combination Therapy Product Market Performance
9.14.4 Guilin Pharmaceuticals Business Overview
9.14.5 Guilin Pharmaceuticals Recent Developments
10 Artemisinin Combination Therapy Market Forecast by Region
10.1 Global Artemisinin Combination Therapy Market Size Forecast
10.2 Global Artemisinin Combination Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Artemisinin Combination Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Artemisinin Combination Therapy Market Size Forecast by Region
10.2.4 South America Artemisinin Combination Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Artemisinin Combination Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Artemisinin Combination Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Artemisinin Combination Therapy by Type (2025-2030)
11.1.2 Global Artemisinin Combination Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Artemisinin Combination Therapy by Type (2025-2030)
11.2 Global Artemisinin Combination Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Artemisinin Combination Therapy Sales (K Units) Forecast by Application
11.2.2 Global Artemisinin Combination Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings